Trials / Conditions / Bladder Pain Syndrome

Bladder Pain Syndrome

61 registered clinical trials studyying Bladder Pain Syndrome — 19 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations NCT06013449	Wake Forest University Health Sciences	N/A
Not Yet Recruiting	Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain Syndrome NCT06863220	Medipol University	N/A
Recruiting	Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis NCT04734106	Wake Forest University Health Sciences	EARLY_Phase 1
Recruiting	Acupuncture First for IC/BPS NCT06366269	University Hospitals Cleveland Medical Center	N/A
Recruiting	Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladde NCT06394830	Vaneltix Pharma, Inc.	Phase 2
Recruiting	Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function NCT06729151	Walter Reed National Military Medical Center	—
Recruiting	Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation NCT06719232	Jahn Ferenc South Pest Teaching Hospital	—
Withdrawn	Auricular Acupressure Therapy for Patients With IC/BPS NCT05857020	Wake Forest University Health Sciences	N/A
Recruiting	Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683	Vanderbilt University Medical Center	N/A
Enrolling By Invitation	Migraine Medication Effects on Urinary Symptoms NCT06212661	The Cleveland Clinic	—
Recruiting	Bladder Botox UTI Antibiotic Prophylaxis NCT06387329	Walter Reed National Military Medical Center	Phase 4
Recruiting	fMRI for BPS: A Descriptive Study of Findings and Symptoms NCT06294951	RenJi Hospital	—
Recruiting	New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome NCT06204874	Walter Reed National Military Medical Center	N/A
Completed	Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis NCT06232200	Medipol University	N/A
Recruiting	The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hu NCT07459790	JSC NextGen	Phase 2 / Phase 3
Recruiting	Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo i NCT05737121	Vaneltix Pharma, Inc.	Phase 2
Withdrawn	Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome NCT05699551	Wake Forest University Health Sciences	N/A
Terminated	A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pa NCT05740007	Ironwood Pharmaceuticals, Inc.	Phase 2
Terminated	A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain NCT05658874	Jocelyn Fitzgerald	Phase 3
Recruiting	Investigation of PEMF Therapy for Female Patients With IC/BPS NCT05149573	Wake Forest University Health Sciences	N/A
Recruiting	EPPIC: Easing Pelvic Pain Interventions Clinical Research Program NCT05127616	State University of New York at Buffalo	N/A
Withdrawn	Intradetrusor Triamcinolone Injection in the Management of Interstitial Cystitis/Bladder Pain Syndrome NCT05226832	The University of Texas Medical Branch, Galveston	N/A
Completed	What is the Optimal Technique for Hydrodistention? NCT05456308	University of Michigan	N/A
Active Not Recruiting	Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome NCT05485207	Stanford University	EARLY_Phase 1
Recruiting	EA for BPS: An RCT and Study for Central Mechanism NCT05279963	The Third Affiliated hospital of Zhejiang Chinese Medical University	N/A
Unknown	Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the E NCT05276466	MicroGenDX	N/A
Unknown	Biopsychosocial and Conventional Approach in Bladder Pain Syndrome NCT05155384	Hacettepe University	N/A
Unknown	GAG-therapy Efficacy Trial Solution for Bladder Pain Syndrome/ Interstitial Cystitis (GETSBI Study) NCT05518864	Radboud University Medical Center	Phase 4
Terminated	IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone NCT04313972	Endeavor Health	Phase 4
Recruiting	Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome NCT04734847	University of Southern California	N/A
Completed	PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome NCT04540887	Wake Forest University Health Sciences	N/A
Withdrawn	The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary Symp NCT04349930	University of New Mexico	Phase 1
Suspended	Low-dose Naltrexone for Bladder Pain Syndrome NCT04450316	Stanford University	Phase 2
Completed	The Female Microbiome in Patients Undergoing Bladder Instillation Therapy NCT05414305	Walter Reed National Military Medical Center	Phase 2
Completed	Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04401176	Walter Reed National Military Medical Center	Phase 2
Completed	Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04275297	Vanderbilt University Medical Center	N/A
Completed	PK and Safety of SI-722 in IC/BPS NCT04208087	Seikagaku Corporation	Phase 1 / Phase 2
Unknown	Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome NCT04789135	Anhembi Morumbi University	Phase 2
Completed	Hypnosis for Bladder Pain Syndrome NCT04010513	University of Pennsylvania	N/A
Completed	Translational Research in Pelvic Pain NCT04001244	University of Oxford	—
Completed	Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis NCT04821882	National Defense Medical Center, Taiwan	N/A
Unknown	Platelet Enriched Plasma for Treatment of Interstitial Cystitis NCT04118946	Mansoura University	Phase 1 / Phase 2
Completed	Clinical Trial Comparing Two Bladder Instillations for IC/BPS NCT03463915	Olivia Cardenas-Trowers, M.D.	Phase 3
Completed	What is the Prevalence of Female Pelvic Floor Disorders in Minnesota? NCT03536221	University of Minnesota	—
Completed	Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome NCT03755375	University of Sao Paulo General Hospital	N/A
Withdrawn	Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women NCT02981459	State University of New York at Buffalo	Phase 4
Completed	A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of NCT03282318	Astellas Pharma Europe B.V.	Phase 2
Unknown	Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453	Aquinox Pharmaceuticals (Canada) Inc.	Phase 3
Terminated	Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder NCT02591199	Urigen	Phase 2
Completed	Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pa NCT03987594	Yonsei University	N/A
Completed	Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A NCT03103594	University of Pennsylvania	EARLY_Phase 1
Unknown	Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis NCT03076762	Buddhist Tzu Chi General Hospital	Phase 2
Withdrawn	Microbiome of Urologic Chronic Pelvic Pain Syndrome NCT03027076	Johns Hopkins University	—
Completed	Efficacy and Safety of AQX-1125 in IC/BPS NCT01882543	Aquinox Pharmaceuticals (Canada) Inc.	Phase 2
Terminated	Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study NCT01879930	Insel Gruppe AG, University Hospital Bern	Phase 4
Completed	Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder P NCT01963988	Samsung Medical Center	—
Terminated	The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Blad NCT01569438	Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrom NCT01895153	Samsung Medical Center	—
Terminated	Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis NCT00517868	Urigen	Phase 2
Recruiting	Identifying Genetic Causes of IC/BPS NCT00389142	Boston Children's Hospital	—
Completed	Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis NCT03023241	Cantonal Hospital, Frauenfeld	N/A